News Center
home > News Center > Hot newslist page
 
 
Liquid Biopsy Continues to Prive Mettle for Ca Genes 2016-07-08
By Charles Bankhead Senior Associate Editor, MedPage Today 6/7/2016 CHICAGO -- The largest-ever study of liquid biopsies showed that half of patients with advanced cancers had tumor mutations that could be matched to FDA-approved cancer drugs, investigators reported here. Almost two-thirds of the 15,191 patients had tumor mutations that could be matched to an approved drug or a treatment under evaluation in ongoing clinical trials. The commercially available blood test also identified resistance mutations that could inform decisions about selecting alternative cancer drugs.
 
 
 
Most US Women Undergoing BRCA Testing Not Receiving Genetic Counseling 2015-10-06
Most US Women Undergoing BRCA Testing Not Receiving Genetic Counseling Jason Hoffman, PharmD, RPh October 02, 2015
 
 
 
Young Cancer Survivors Often Develop New Malignancies 2015-10-06
Young Cancer Survivors Often Develop New Malignancies TUESDAY, Oct. 6, 2015 (HealthDay News) -- Teen and young adult cancer survivors are at increased risk for other cancers later in life, a new study reveals.
 
 
 
More Evidence Daily Aspirin May Fight Colon Cancer 2015-04-13
4-year study found survival doubled for gastrointestinal cancer patients who took low-dose pill each day .
 
 
 
Providers Must Understand Legal Limits of Telemedicine 2015-04-13
Providers should ensure they hold proper medical license and have medical liability coverage
 
 
 
Related Category
Promotion Products
More
 
 
  • Partners
  • Links
USCAP  |   CAP  |   IAP  |   TPIS  |   ASC  |   CAP-ACP  |   ASIP  |   AMP  |   ASCP  |   CAPA  |  
Home  |  News  |  Journals  |  Cases  |  Lectures  |  Experts  |  Telepath  |  Research  |  Conferences  |  Job_Position  |  Books  |  Sponsors
2009-2015 All Rights Reserved GoPath Diagnostics, LLC.